What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation.
about
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancerRelationship and interactions of curcumin with radiation therapyRadiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted".Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer.Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodesConventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialSalvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.Dosimetric impact in the dose-volume histograms of rectal and vesical wall contouring in prostate cancer IMRT treatments.Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis.Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer.Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG.Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition).Chemotherapy and radiation for prostate cancer
P2860
Q26738278-F2138611-0E93-46D0-8887-DA114847D27EQ26746150-2C73EB89-191A-43D5-8ACB-14265CF3CC6DQ36241918-8CC083D2-2B97-4312-A941-EB1A8012B142Q36918476-E2235BC8-90D1-4907-B057-34148751BC25Q37109702-6B2C5138-BDFA-4441-8941-83BCB35AEBF6Q37128114-4C4E33CA-9109-4888-85FB-09992B19FAD1Q38705877-C92663D7-8268-47BE-A7A8-C2DB8E62B97AQ38810088-A7A1E18B-DD81-49DE-8CB0-D13B57A1EB78Q41960300-5D3BB4B5-00EC-47C8-9AE2-7581D1719D39Q44514013-FCAA0D68-5E39-4154-BE17-153089C9E378Q44927261-C7C44BD7-2283-4895-9396-2D0E00A4E942Q48276400-F9B4DAA1-F5B7-4152-B8A0-57193F4DB071Q48325008-27220661-4CE3-4097-9315-E7131E420096Q53734447-484BB6BA-96AC-457C-89FC-7E9450BDD50AQ57112428-5F1671EF-A066-417F-8528-280F424F5144
P2860
What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
What is the ideal radiotherapy ...... ly equivalent dose escalation.
@en
type
label
What is the ideal radiotherapy ...... ly equivalent dose escalation.
@en
prefLabel
What is the ideal radiotherapy ...... ly equivalent dose escalation.
@en
P2093
P50
P1476
What is the ideal radiotherapy ...... lly equivalent dose escalation
@en
P2093
Adam P Dicker
Mark D Hurwitz
Scott W Keith
P304
P356
10.1016/J.RADONC.2015.05.011
P577
2015-05-28T00:00:00Z